Literature DB >> 19567527

Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.

Manuel Maliqueo1, Teresa Sir-Petermann, Virginia Pérez, Bárbara Echiburú, Amanda Ladrón de Guevara, Carla Gálvez, Nicolás Crisosto, Ricardo Azziz.   

Abstract

CONTEXT: In some patients, PCOS may develop as a consequence of an exaggerated adrenarche during pubertal development.
OBJECTIVE: The aim of the study was to assess adrenal function during childhood and pubertal development in daughters of women with PCOS (PCOSd).
DESIGN: We included 98 PCOSd [64 during childhood (ages 4-8 yr) and 34 during the peripubertal period (ages 9-13 yr)] and 51 daughters of control women (Cd) [30 during childhood and 21 during the peripubertal period]. In both groups, an acute ACTH-(1-24) stimulation test (0.25 mg) and an oral glucose tolerance test were performed. Bone age and serum concentrations of cortisol, androstenedione, 17-hydroxyprogesterone, dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), glucose, and insulin were determined.
RESULTS: PCOSd and Cd were similar in age and body mass index. During the peripubertal period, basal and poststimulated DHEAS concentrations were higher in PCOSd compared to Cd. Among PCOSd, 12.5% of girls in childhood and 32.4% in peripuberty presented biochemical evidence of exaggerated adrenarche. Stimulated insulin was higher in PCOSd compared to Cd during childhood (P = 0.03) and peripuberty (P = 0.03). An advancement of 8 months between bone and chronological age was observed in peripubertal PCOSd compared to Cd.
CONCLUSIONS: In PCOSd, basal and stimulated DHEAS concentrations were higher during the onset of puberty. Around 30% of the PCOSd demonstrated an exacerbated adrenarche, which may reflect increased P450c17 activity. In addition, a modest advance in bone age was observed, probably secondary to the hyperinsulinemia and/or adrenal hyperandrogenism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567527     DOI: 10.1210/jc.2009-0427

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives.

Authors:  Laura C Torchen; Naomi R Fogel; Wendy J Brickman; Rodis Paparodis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

Review 2.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 3.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

Review 4.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

5.  Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study.

Authors:  Richard S Legro; Allen R Kunselman; Christy M Stetter; Carol L Gnatuk; Stephanie J Estes; Eleanor Brindle; Hubert W Vesper; Julianne C Botelho; Peter A Lee; William C Dodson
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

6.  Maternal polycystic ovarian syndrome and offspring growth: the Upstate KIDS Study.

Authors:  Griffith A Bell; Rajeshwari Sundaram; Sunni L Mumford; Hyojun Park; Miranda Broadney; James L Mills; Erin M Bell; Edwina H Yeung
Journal:  J Epidemiol Community Health       Date:  2018-05-22       Impact factor: 3.710

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 8.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

9.  Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome.

Authors:  Andréanne Trottier; Marie-Claude Battista; David H Geller; Brigitte Moreau; André C Carpentier; Judith Simoneau-Roy; Jean-Patrice Baillargeon
Journal:  Fertil Steril       Date:  2012-09-15       Impact factor: 7.329

Review 10.  Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Bulent Yilmaz; Priyathama Vellanki; Baris Ata; Bulent Okan Yildiz
Journal:  Fertil Steril       Date:  2018-01-11       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.